Listeria infection results in the induction of gamma interferon (IFN-␥)-producing T lymphocytes. Blocking of the costimulatory molecule B7 in vivo led to a marked decrease in antigen-specific production of IFN-␥ and interleukin-2 by lymphocytes. Blocking of both B7-1 (CD80) and B7-2 (CD86) was required in order to inhibit cytokine production, indicating that either molecule could act alone. Although IFN-␥ production by cultured spleen cells was significantly suppressed by B7 blocking, mice cleared primary and secondary Listeria infection as effectively as control mice.
Clearance of infection with facultative intracellular bacterial pathogens such as Listeria monocytogenes is accompanied by the induction of gamma interferon (IFN-␥)-producing CD4
ϩ Th1 cells (10) . Induction of Th1 cells is greatly influenced by Th1-promoting cytokines, such as interleukin-12 (IL-12) (19) , as well as costimulatory molecules expressed on antigen-presenting cells (11, 18) . Recent studies indicate that the B7/CD28 costimulatory pathway plays a complex and important role in regulating the in vivo immune response. CD28 interacts with two different ligands, designated CD80 (B7-1) and CD86 (B7-2). By using B7-1 and B7-2 transfectants as antigen-presenting cells in vitro, Lanier et al. (13) found that the ligands provided similar costimulatory signals for T-cell proliferation and production of IL-2 and IFN-␥. They also demonstrated that blocking of both B7-1 and B7-2 was required for optimal inhibition of the allogeneic mixed-lymphocyte reaction. However, this has not been found consistently. Freeman et al. (5) found that B7-2 stimulated more IL-4 production than did B7-1. Kuchroo et al. (12) also demonstrated in an autoimmune model that B7-1 preferentially acted as a costimulator for the generation of Th1 cells whereas B7-2 costimulated Th2 cells. In the present study, we investigated the role of B7-1 and B7-2 in induction of Th1 cells in response to the intracellular bacterium L. monocytogenes by blocking of B7-1 and/or B7-2 with monoclonal antibodies (MAbs) to B7-1 and B7-2 in vivo.
Anti-B7-1 (1G10) and anti-B7-2 (GL1) antibodies have been described previously (7, 15) , and hybridomas were kindly supplied by Andrew Strassor of Walter and Eliza Hall Institute, Melbourne, Australia. Hybridomas were grown as ascites and purified by 50% ammonium sulfate precipitation. To block B7 in vivo, C57BL/10 mice were given three injections of 2 mg of anti-B7-1 MAb, 2 mg of anti-B7-2 MAb, or 1 mg each of both anti-B7-1 and anti B7-2 antibody every other day, starting 2 days before mice were infected with 2 ϫ 10 4 L. monocytogenes organisms and continuing until 2 days after. Mice were sacrificed 7 days after infection. Spleen cells were prepared from anti-B7-treated mice and control mice and were cultured at a concentration of 2 ϫ 10 6 cells per ml in 2-ml volumes in 24-well tissue culture trays (Nunc, Roskilde, Denmark) in the presence or absence of 2 ϫ 10 8 heat-killed Listeria organisms per ml for 24 h. Culture supernatants were tested for IL-2, IFN-␥, and IL-4 by bioassay as described previously (20) . Nitric oxide (NO) production by spleen cells was determined by the Griess reaction as described previously (21) . Culture supernatants (50 l) were mixed with 100 l of 1% sulfanilamide (Sigma, St. Louis, Mo.) and 100 l of 0.1% N-(1-naphthyl)ethylenediamine dihydrochloride in 2.5% polyphosphoric acid (Sigma) at room temperature for 5 min. The A 540 was measured. NO was quantified by comparison to an Na(NO 2 ) (Sigma) standard. Bacterial numbers in the liver and spleen were also determined 7 days after infection. The study reported here shows that the production of IL-2 and IFN-␥ by spleen cells from mice 7 days postinfection was greatly reduced in mice depleted of both B7-1 and B7-2 compared with the cytokine production by the spleen cells from control infected mice (Fig. 1) . However, mice treated with either anti-B7-1 or anti-B7-2 had a cytokine profile similar to that of control infected mice. No IL-4 was detectable in any of the bulk cultures (Ͻ50 pg/ml [data not shown]). Three repeated experiments gave similar results.
Therefore, these results suggested that either B7-1 or B7-2 was required for Th1-cell development and that the molecules exhibited similar activities. These results agree with the findings demonstrated by Lanier et al. (13) that either B7-1 or B7-2 could efficiently costimulate T-cell proliferation and the production of IL-2 and IFN-␥ by the T cells. On the other hand, our results are in contrast to the finding by Kuchroo et al. that B7-1 and B7-2 activate, respectively, Th1 and Th2 cells, both in vitro and in vivo (12) . Interestingly, Freeman et al. (5) showed that B7-1 and B7-2 costimulated IL-2 and IFN-␥ production but that B7-2 induced significantly more IL-4 production than B7-1, suggesting that B7-2 directed the immune response towards Th0 and Th2 whereas B7-1 is a more neutral differentiative signal. In our experiments, no significant levels of were detected in the cultures of the spleen cells from either anti-B7-1-or anti-B7-2-treated mice. Since natural killer (NK) cells express CD28 on their surfaces and require CD28-mediated costimulatory signals for optimal proliferation (16), it is possible that B7 blocking diminished IFN-␥ production not only by T cells but also by NK cells. It will be worthwhile to further investigate the influence of the CD28 costimulatory pathway on cytokine production by NK cells.
IFN-␥ plays an important role in clearing intracellular bacterial infection, as it has been demonstrated that listerial infection in IFN-␥-depleted mice or IFN-␥ receptor-deficient mice was severely exacerbated (2, 8) . Although in vivo blocking of B7 resulted in a great reduction of IFN-␥ production by cultured spleen cells, clearance of the primary listerial infection was not hampered in the anti-B7-treated mice (Fig. 2) . Interestingly, production of NO, a major mediator of macrophage killing of Listeria organisms (1), was unchanged in the anti-B7-treated mice, despite the severe reduction in IFN-␥ production by cultured spleen cells (Fig. 1) . IFN-␥ is the major, but not the only, activator of NO production by macrophages (4). Therefore, this macrophage activation could be due to residual IFN-␥ production as demonstrated by the cultured T cells, IFN-␥ production by NK cells, which are normally activated 1 to 3 days postinfection (3), or to other cytokines.
When mice treated with anti-B7 MAb during primary infection were rechallenged with 10 5 Listeria organisms 1, 2, or 5
FIG. 1. Effect of blocking B7-1 and/or B7-2 on production of lymphokines and NO. Mice were injected intravenously with 2 ϫ 10 4 live L. monocytogenes organisms. To block B7 in vivo, mice were also given three injections of 2 mg of anti-B7-1 MAb, 2 mg of anti-B7-2 MAb, or 1 mg of both at days Ϫ2, 0, and 2 relative to the day of infection. Mice were killed 7 days after infection. Spleen cells were prepared from each group and cultured at 2 ϫ 10 6 cells per ml in 2-ml volumes in 24-well plates, in the presence of 2 ϫ 10 8 heat-killed L. monocytogenes organisms per ml. IFN-␥ and IL-2 in 24-h culture supernatants and NO in 72-h culture supernatants were assayed. Data are the means and standard deviations of triplicate cultures. Culture supernatants from the above-described groups in the absence of in vitro heat-killed listeriae and from spleen cells from nonimmunized mice both in the absence and presence of heat-killed listeriae had undetectable levels of IL-2 (Ͻ0.03 U/ml) and IFN-␥ (Ͻ1 U/ml).
FIG. 2.
Effect of blocking B7-1 and/or B7-2 on resistance to Listeria infection. Treatment of mice was the same as for Fig. 1 . Mice were killed 7 days after infection. The spleens and livers were removed and homogenized in 5 ml of sterilized phosphate-buffered saline (pH 7.2). Bacterial numbers in the suspension were determined by placing serially diluted samples on horse blood agar plates. Results are represented as the means and standard deviations for three to five mice. The detection limit is log 2.6, and the differences are not statistically significant (Student's t test). Results are typical of three representative experiments. weeks later, these mice cleared infection as effectively as mice which had primary infection but which were not treated with anti-B7 MAb ( Table 1) . Recall of IFN-␥ production by cultured T cells at these times was much reduced by anti-B7 treatment during primary infection (Table 1) . Macrophage activation resulting from primary infection can last up to 2 weeks and may account for protection against early secondary challenge (17). However, protection after 5 weeks reflects true immunological memory. It has been shown that immunological memory to listeria infection is primarily due to CD8 ϩ T cells (9) and that this may be IFN-␥ independent (6). While we have not directly tested the effect of anti-B7 treatment on CD8 ϩ T-cell activation, these results imply that it may be unaffected. Alternatively, it is possible that incomplete blocking of B7-1 and B7-2 or an alternative costimulatory molecule, such as B7-3 (14) , can still activate T cells to produce a low level of IFN-␥ to counter the infection.
Overall, the regulator or effector role of cytokines in the immune response has received the most attention, while the role of cell surface costimulatory molecules in regulating the immune response, especially that to intracellular pathogens, is still relatively unexplored. The present study indicated that these costimulatory molecules were critical to induction of the Th1 response to listerial infection. Further study is needed for better understanding of their functions and expression in response to intracellular pathogens.
